Posts by: Jose Marques Lopes, PhD

News

The U.S. Food and Drug Administration granted fast track status to Polyphor’s immuno-oncology candidate balixafortide (POL6326) in combination with Halaven (eribulin mesylate) to treat a subset of patients with ... Read more

April 16, 2018

New Breast Cancer Research Tool Looks at Tumor Biology, Predicts Treatment Response

News

NanoString launched a new research panel to allow for a more rapid and complete view of breast cancer and its associated immune response. The new Breast Cancer 360 (BC 360) ... Read more

April 4, 2018

EMA to Decide if Lynparza Can Treat BRCA-mutated Metastatic Breast Cancer Patients

News

The European Medicines Agency has agreed to review an application by AstraZeneca and MSD requesting the approval of Lynparza (olaparib) for the treatment of patients with a difficult-to-treat type of metastatic breast cancer ... Read more

March 12, 2018March 12, 2018

New Blood Test Quickly Predicts Ibrance Treatment Response in Breast Cancer Patients, Study Shows

News

A new blood test could predict how a patient will respond to metastatic breast cancer medication Ibrance (palbociclib) months earlier than current approaches, a U.K. study suggests. Research shows ... Read more

February 1, 2018

Patient Dosing Begins in Phase 2 Trial of MCLA-128 in Metastatic Breast Cancer

News

The first patient in the Phase 2 clinical study of MCLA-128 in metastatic breast cancer patients has been dosed, The Netherlands-based immuno-oncology company Merus recently announced. The international study ... Read more

September 25, 2017

Tibetan Yoga May Improve Sleep Quality in Breast Cancer Patients on Chemotherapy, Study Finds

News

Practicing Tibetan yoga frequently may improve sleep quality in breast cancer patients receiving chemotherapy, research from The University of Texas MD Anderson Cancer Center shows. The study, “Randomized trial ... Read more

Posts by: Jose Marques Lopes, PhD

Jose Marques Lopes, PhD

FDA Grants Fast Track Status to Breast Cancer Therapy Candidate Balixafortide Combined with Halaven

New Breast Cancer Research Tool Looks at Tumor Biology, Predicts Treatment Response

EMA to Decide if Lynparza Can Treat BRCA-mutated Metastatic Breast Cancer Patients

New Blood Test Quickly Predicts Ibrance Treatment Response in Breast Cancer Patients, Study Shows

Patient Dosing Begins in Phase 2 Trial of MCLA-128 in Metastatic Breast Cancer

Tibetan Yoga May Improve Sleep Quality in Breast Cancer Patients on Chemotherapy, Study Finds

Pin It on Pinterest